Medical Device Industry

Found 6,236 articles

• Bryn Pharma Partners with Aptar Pharma for Nasal Epinephrine Treatment

  10/21/2019

  Bryn Pharma, LLC ("Bryn" or the "Company"), today announced that it has entered into an agreement with Aptar Pharma (AptarGroup NYSE: ATR), a leading drug delivery systems provider, for the supply and worldwide exclusive right to use Aptar's novel, FDA-approved Bidose (BDS) nasal device for the delivery of epinephrine to treat anaphylaxis.

• Medigate Named as Hot IoT Startup to Watch in Big50-2019 Startup Report

  10/21/2019

  Medigate has been named a “Hot Startup to Watch” in the Internet of Things (IoT) category for Startup50’s Big50-2019 Startup Report, which spotlights 50 startups that have gained a foothold in fast-growth tech sectors.

• Soliton to Announce Keloid Trial Data on October 25, 2019 and Host Webcast at 5:30PM ET to Discuss Results

  10/21/2019

  Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announces it will host a webcast to present the company's interim keloid and hypertrophic scar proof-of-concept ("POC") trial data on October 25, 2019 at 5:30 p.m. ET. 

• Large Complex Polyps Removed Successfully From Three Patients Without Surgical Intervention Using Lumendi DiLumen C2™

  10/21/2019

  A large complex sigmoid polyp in a 62-year-old male patient was successfully removed in a 60-minute procedure without surgical intervention using DiLumen C2, a second-generation endoscopic dual balloon colon stabilization accessory that employs two 6mm working channels that accommodate several flexible therapeutic instruments designed to efficiently retract and dissect tissue.

• Orthofix Schedules Third Quarter 2019 Earnings Release and Conference Call for October 28, 2019

  10/21/2019

  Orthofix Medical Inc., a global medical device company focused on musculoskeletal products and therapies, announced that it plans to release financial results for the third quarter 2019 after market close on Monday, October 28, 2019.

• BIOLASE Announces Select Preliminary Third Quarter 2019 Financial Results And Date For Reporting Third Quarter 2019 Results

  10/21/2019

  BIOLASE, Inc., the global leader in dental lasers, announced select unaudited preliminary financial results for the third quarter ended September 30, 2019.

• Shape Memory Medical Receives CE Mark for the TrelliX® Embolic Coil System

  10/21/2019

  Shape Memory Medical Inc. announced it has received CE mark for its TrelliX® Embolic Coil System.

• Perflow Medical Receives CE Mark Approval of Novel Cascade™ Agile

  10/21/2019

  Promising clinical data for Cascade Net published in the Journal of NeuroInterventional Surgery

• IRRAS Announces Participation at the 69th Congress of Neurological Surgeons' Annual Meeting (CNS 2019)

  10/18/2019

  IRRAS announced that it will be participating at the 69th Congress of Neurological Surgeons' Annual Meeting CNS 2019 is being held at the Moscone Center, West Building, in San Francisco, CA on October 19-23, 2019.

• Natus Medical Announces Transition of Peloton Business to Pediatrix Medical Group and Signing of Strategic Agreement

  10/17/2019

  Natus Medical Incorporated announced that the Company signed a definitive agreement to transition its Peloton hearing screening services business to Pediatrix Medical Group After the completion of the transition, Pediatrix will manage all newborn hearing screening services for Peloton hospitals.

• Innovative Cancer Treatment Medical Device Company Appoints Dr. Jonathan Jarow, MD as Chief Medical Officer

  10/17/2019

  Francis Medical, Inc. announced the appointment of Dr. Jonathan Jarow as the company’s chief medical officer Dr. Jarow will be leading Francis Medical’s clinical and regulatory efforts, including the VAPOR trials evaluating water vapor ablation as a minimally invasive treatment for prostate cancer.

• Sernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in its Phase I/II Clinical Trial for Type-1 Diabetes

  10/16/2019

  Findings further validate Cell Pouch and therapeutic cell performance in

• BioDirection, Inc. Announces Move of Corporate Headquarters to Southborough, Massachusetts

  10/16/2019

  BioDirection, Inc., a privately held medical device company developing cutting-edge and rapid point-of-care products for the objective diagnosis and management of concussion and other traumatic brain injuries, today announced that the company has leased a 5,000 sq. ft. facility in Southborough, Massachusetts for its new corporate headquarters.

• Fidmi Medical Receives FDA Regulatory Clearance for Low-profile Enteral Feeding Device

  10/16/2019

  Fidmi Medical Ltd. a portfolio company of The Trendlines Group Ltd. ("Trendlines") (SGX: 42T) (OTCQX: TRNLY), announced today that it received 510K regulatory clearance from the United States Food and Drug Administration (FDA) for its low-profile enteral feeding device.

• Beyond Air™ Provides Update on High Concentration Nitric Oxide (NO) Animal Studies Using LungFit™Data support planned clinical studies, including a pivotal bronchiolitis (BRO) study and an at-home nontuberculous mycobacteria (NTM) study

  10/16/2019

  Beyond Air, Inc. announced the successful completion of a 30-day rat toxicology study and provided an update on its 12-week toxicology studies in both rats and dogs.

• IRADIMED CORPORATION to Hold 2019 Third Quarter Financial Results Conference Call on October 30th

  10/16/2019

  IRADIMED CORPORATION announced that the Company will release its 2019 third quarter financial results before the market opens on Wednesday, October 30th.

• Neovasc Retains Westwicke, ICR for Integrated Communications Counsel

  10/16/2019

  Company Ramps Up Commercialization of Neovasc Reducer™ and Development of Tiara™ Product Platforms, Primes for Pivotal Growth Period

• Tandem Diabetes Care Announces NEJM Publication of Landmark Study Demonstrating Increased Time-In-Range with the t:slim X2 Insulin Pump with Control-IQ Technology

  10/16/2019

  Tandem Diabetes Care, Inc. announced publication by the New England Journal of Medicine of results from the landmark Protocol 3 study of the National Institutes of Health -funded International Diabetes Closed Loop trial using the t:slim X2™ insulin pump with Control-IQ™ advanced hybrid closed-loop technology.

• American BriVision Highlights Results from Vitargus® First-in-Human Clinical Trial

  10/15/2019

  American BriVision (Holding) Corporation (OTCQB: ABVC) (the “Company”), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced encouraging results from the First-in-Human Clinical Trial (“feasibility study” or “study”) for Vitargus®, the Company’s investigational medical device.

• Neovasc Announces Notice of US Patent Granted for Tiara™ Transcatheter Device for Treatment of Severe Mitral Regurgitation

  10/15/2019

  Neovasc, Inc. announced that the United States Patent and Trademark Office has issued US Patent No. 10,433,952, titled: “PROSTHETIC VALVE FOR AVOIDING OBSTRUCTION OF OUTFLOW”.